caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1134193469

Mark HigginsMD

Internal MedicineSan Francisco, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (4)

CCN 059016
Home health agency
CCN 050008
Hospital
CCN 050047
Hospital
CCN 050454
Hospital
REFERRAL NETWORK

Where Mark Higgins's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 7 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Thomas Kaiser
Cardiology · San Francisco, CA
1547
Virginia Cafaro
Internal Medicine · San Francisco, CA
1557
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
SUTTER BAY HOSPITALS70329
SUTTER BAY HOSPITALS2880
Laboratory Corporation Of America
Clinical Laboratory · San Diego, CA
2156
Quest Diagnostics Nichols Institute
Clinical Laboratory · San Juan Capistrano, CA
2145
Virginia Cafaro
Internal Medicine · San Francisco, CA
1846
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1249
Samuel Ellison
Dermatology · San Francisco, CA
1132
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
500
Unique beneficiaries
—
Total services
713
Distinct HCPCS
9
Medicare payment
$73K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10,499 Internal Medicine providers in CA — above median (cohort median 531).
QUALITY · MIPS · 2024
Final MIPS score
84.3
Quality
71.8
Cost
75.9
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Individual
PRESCRIBING · PART D · 2024
Total Rx claims
12,134
Beneficiaries
—
Total drug cost
$9.6M
Distinct drugs
187
Brand share
40.9%
Top prescribed drugs
Atorvastatin Calcium532 claims
Bictegrav/Emtricit/Tenofov Ala409 claims
Acyclovir270 claims
Emtricitabine/Tenofov Alafenam254 claims
Dolutegravir Sodium251 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$6K
Payment records
257
By payment type
Food and Beverage$6K